J Asthma Allergy Clin Immunol.  2002 Mar;22(1):119-123.

Two cases of rifampin desensitization in AIDS patients with rifampin hypersensitivity

Affiliations
  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. haesunfree@yonsei.md
  • 2Institute of Allergy, Yonsei University College of Medicine, Division of Infectious Disease, Seoul, Korea.

Abstract

Adverse reactions to drugs are more common in HIV infected patients. Hypersensitivity to trimethoprim-sulfamethoxazole (TMP/SMZ) during treatment or prophylaxis of Pneumocystis carinii pneumonia (PCP) is the most frequent drug reaction of HIV infection. Although less extensively documented than sulphonamides, other drugs also seem to induce drug reactions in HIV-seropositive patients more than in other groups. Rifampin is an essential anti-tuberculosis medication; thus, desensitization of rifampin is especially necessary in our country in which mycobacterial infection is common. We report two cases of AIDS patients with pulmonary tuberculosis who have rifampin hypersensitivity whose rifampin treatment will end successfully through rifampin desensitization.

Keyword

AIDS; rifampin hypersensitivity; desensitization

MeSH Terms

HIV
HIV Infections
Humans
Hypersensitivity*
Pneumonia, Pneumocystis
Rifampin*
Trimethoprim, Sulfamethoxazole Drug Combination
Tuberculosis, Pulmonary
Rifampin
Full Text Links
  • JAACI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr